Free for publication on September 29, 2021, at 10.00 a.m. (CEST +1)
Oulu, Finland, September 29, 2021 – Bittium, a leading specialist for secure communications, connectivity, and medical technology solutions, releases a new version of Bittium Cardiac Navigator™ Holter ECG Analysis Software. The new Bittium Cardiac Navigator™ 1.5. Software version introduces the detection of atrioventricular blocks (AV blocks). The application now automatically detects first- and second-degree atrial conduction disorders. The automatic noise detection has also been renewed, which enables even more efficient and faster analysis of measurements.
”Cardiac Navigator is used by numerous Faros ECG device customers. The new software version is now even more efficient and user-friendly. In addition to the improvements mentioned above, the application's user interface has been clarified and its color scheme has been made more appealing than before. Especially, the completely revamped Templates tool streamlines the traditional beat classification, which is the backbone of high-quality ECG analysis”, says Arto Pietilä, Senior Vice President, Bittium Medical Technologies.
Bittium Cardiac Navigator™ software solution is designed for analyzing clinical Holter ECG recordings. Based on recordings, the software provides information about the electrical cardiac activity of the heart, and in particular, about arrhythmia and other exceptional events. Its user-friendly and informative data presentation and intuitive analysis tools make the software efficient and easy to use when analyzing multiple days of ECG recordings. The software allows for scanning long measurements efficiently in a shorter time, thus speeding up the final diagnosis.
Bittium Cardiac Navigator™ software is immediately available for installation. More information on the offering: https://www.bittium.com/medical/bittium-cardiac-navigator and email@example.com .
Senior Vice President, Medical Technologies
Tel. +358 (0)40 344 3507
Bittium specializes in the development of reliable, secure communications and connectivity solutions, leveraging its 35-year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. In the field of healthcare technology, Bittium offers solutions for the measurement and monitoring of biosignals in the areas of cardiology, neurophysiology, rehabilitation, occupational health and sports medicine. Net sales in 2020 were EUR 78.4 million and operating profit was EUR 2.1 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com